MAP
EXEL icon

Moody Aldrich Partners’s Exelixis EXEL Stock Holding History

Moody Aldrich Partners’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-49,595
Closed -$634K – 94
2016
Q3 		$634K Buy
+49,595
New +$536K 0.44% 89

Other funds holding EXEL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Moody Aldrich Partners's EXEL Position: Q4 2016 in Review

Moody Aldrich Partners sold out of Exelixis (EXEL) in Q4 2016, closing a stake of 49,595 shares — an estimated $634K sold.

Moody Aldrich Partners first reported a position in EXEL in Q3 2016 and held it in 1 quarter. The position peaked at $634K in Q3 2016. 228 funds tracked by Wall St. Rank hold EXEL as of Q4 2016.

  • Moody Aldrich Partners reported no remaining Exelixis position as of Q4 2016 after selling out during the quarter.
  • Moody Aldrich Partners sold 49,595 Exelixis shares in Q4 2016, an estimated $634K.
  • Moody Aldrich Partners first reported a position in Exelixis in Q3 2016 and held it in 1 quarter.
  • Moody Aldrich Partners's Exelixis position peaked at $634K in Q3 2016.
  • 228 funds tracked by Wall St. Rank held Exelixis as of Q4 2016.

Based on Moody Aldrich Partners's 13F filing for Q4 2016, filed 17 Jan 2017.